Pharma stocks up on US tariff exemptions but analyst flags a $46B import cost risk

Pharma stocks up on US tariff exemptions but analyst flags a $46B import cost risk#Pharma #stocks #tariff #exemptions #analyst #flags #46B #import #cost #risk